Peer-influenced content. Sources you trust. No registration required. This is HCN.
Medical News Today (MNT)
The 2026 ACC/AHA dyslipidemia guideline reintroduces LDL-C treatment targets, expands risk assessment, and recommends universal Lp(a) screening. New analyses suggest many US adults now exceed recommended cholesterol thresholds, although treatment decisions remain individualized.
Cardiology August 11th 2026
“Those with very extreme Lp(a) levels have an almost 10% higher absolute risk of developing CVD across 30-years of follow-up.” – Ask T. Nordestgaard, lead author
Cardiology January 27th 2026
MDLinx
“The main scenario that prompts me to use apoB is when a patient’s traditional lipid panel values are either normal, or even slightly abnormal, but have discrepancy with the quality/quantity of their other comorbid problems.” — Austin Shuxiao, MD
Cardiology September 16th 2025
Journal of the American College of Cardiology (JACC)
Elevated plasma Lp(a) concentrations were associated with a 41% faster progression of peak aortic jet velocity and a 57% faster progression of mean transvalvular gradient in patients with aortic stenosis.
Cardiology August 5th 2024
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS